Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

  • Hyman B. Muss
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Donald A. Berry
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Constance T. Cirrincione
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Maria Theodoulou
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Ann M. Mauer
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Alice B. Kornblith
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Ann H. Partridge
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Lynn G. Dressler
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Harvey J. Cohen
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Heather P. Becker
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Patricia A. Kartcheske
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Judith D. Wheeler
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Edith A. Perez
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Antonio C. Wolff
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Julie R. Gralow
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Harold J. Burstein
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Ahmad A. Mahmood
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Gustav Magrinat
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Barbara A. Parker
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Ronald D. Hart
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Debjani Grenier
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Larry Norton
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Clifford A. Hudis
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...
  • Eric P. Winer
    From the University of Vermont, Burlington (H.B.M.); the M.D. Anderson Cancer Center, Houston (D.A.B.); the Cancer and Leukemia Group B (CALGB) Statistical Center, Duke University Medical Center (C.T.C., P.A.K.) and Duke University Medical Center (H.J.C., J.D.W., A.A.M.) — both in Durham, NC; Memorial Sloan-Kettering Cancer Center, New York (M.T., L.N., C.A.H.); CALGB, Chicago (A.M.M., H.P.B.); the Dana–Farber Cancer Institute, Boston (A.B.K., A.H.P., H.J.B., E.P.W.); the University of North...

書誌事項

公開日
2009-05-14
DOI
  • 10.1056/nejmoa0810266
公開者
Massachusetts Medical Society

この論文をさがす

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ